HEMATOPOIETIC STEM CELL TRANSPLANT
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple sugar protect bone marrow transplant patients?
Disease control CompletedThis study tested whether a sugar called 2'-fucosyllactose (2FL) is safe and can help maintain gut health in 70 people receiving a bone marrow transplant. The goal was to see if it reduces infections and a complication called graft-versus-host disease. Participants took the suppl…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can Real-World data unlock clues to a deadly Post-Transplant complication?
Knowledge-focused CompletedThis study looks back at medical records of children and adults who developed a serious blood-clotting condition called thrombotic microangiopathy (TMA) within a year after a stem cell transplant. Researchers aim to understand survival rates and causes of death in these patients,…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC